Published in Am J Ophthalmol on February 01, 2005
Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol (2008) 1.15
Multifocal electroretinography in HIV-positive patients without infectious retinitis. Am J Ophthalmol (2008) 1.08
Imaging of long-term retinal damage after resolved cotton wool spots. Ophthalmology (2009) 1.02
Machine learning classifiers detect subtle field defects in eyes of HIV individuals. Trans Am Ophthalmol Soc (2007) 0.97
Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection. Am J Ophthalmol (2012) 0.95
A degenerative retinal process in HIV-associated non-infectious retinopathy. PLoS One (2013) 0.92
Relationship between retinal nerve fiber layer thickness and driving ability in patients with human immunodeficiency virus infection. Graefes Arch Clin Exp Ophthalmol (2011) 0.85
Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART. Graefes Arch Clin Exp Ophthalmol (2010) 0.83
Analysis with support vector machine shows HIV-positive subjects without infectious retinitis have mfERG deficiencies compared to normal eyes. Trans Am Ophthalmol Soc (2008) 0.83
Retinal Thickening and Photoreceptor Loss in HIV Eyes without Retinitis. PLoS One (2015) 0.80
Retinal nerve fibre layer thickness and contrast sensitivity in HIV-infected individuals in South Africa: a case-control study. PLoS One (2013) 0.80
Visual function assessment in simulated real-life situations in HIV-infected subjects. PLoS One (2014) 0.78
Human immunodeficiency virus and its effects on the visual system. Infect Dis Rep (2012) 0.77
Optic nerve head morphology and visual field function in patients with AIDS and without infectious retinitis. Ocul Immunol Inflamm (2012) 0.76
Retinal Nerve Fiber and Optic Disc Morphology in Patients with Human Immunodeficiency Virus Using the Heidelberg Retina Tomography 3. PLoS One (2015) 0.75
Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS. Ophthalmology (2015) 0.75
Optical coherence tomography. Science (1991) 57.87
Optical coherence tomography of the human retina. Arch Ophthalmol (1995) 8.90
Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86
Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology (1996) 7.00
Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol (2004) 3.79
Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology (1985) 2.89
The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol (2000) 2.33
Retinal nerve fiber layer thickness in normal human eyes. Ophthalmology (1996) 2.26
Retinal thickness decreases with age: an OCT study. Br J Ophthalmol (2003) 2.11
Optical tomography-measured retinal nerve fiber layer thickness in normal latinos. Invest Ophthalmol Vis Sci (2003) 2.00
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82
Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci (2000) 1.71
Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis (2000) 1.63
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (2002) 1.48
Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology (2003) 1.48
Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44
Detecting the inner and outer borders of the retinal nerve fiber layer using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2002) 1.38
Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol (1989) 1.29
Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol (1997) 1.22
Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol (1996) 1.16
Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.11
Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol (1999) 1.08
HIV-related ocular microangiopathic syndrome and color contrast sensitivity. Invest Ophthalmol Vis Sci (1994) 1.08
Optical coherence tomography in measuring retinal nerve fiber layer thickness in normal subjects and patients with open-angle glaucoma. Chin Med J (Engl) (2001) 1.04
Deficits in perimetric performance in patients with symptomatic human immunodeficiency virus infection or acquired immunodeficiency syndrome. Am J Ophthalmol (1995) 1.00
Pattern electroretinograms and visual evoked potentials in HIV infection: evidence of asymptomatic retinal and postretinal impairment in the absence of infectious retinopathy. Neurology (1996) 0.99
Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophthalmol (2001) 0.96
Effect of pupillary dilation on retinal nerve fiber layer thickness measurements using optical coherence tomography. J Glaucoma (2004) 0.92
Cotton-wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion. Arch Ophthalmol (1988) 0.92
Impairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS. Br J Ophthalmol (1993) 0.90
Evaluation of heredity as a determinant of retinal nerve fiber layer thickness as measured by optical coherence tomography. Invest Ophthalmol Vis Sci (2003) 0.86
Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Arch Ophthalmol (1996) 0.80
Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology (1997) 0.80
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina (2007) 2.15
The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol (2008) 2.10
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology (2012) 1.82
Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina (2008) 1.78
Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application. Ophthalmology (2010) 1.64
The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol (2010) 1.63
Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina (2006) 1.61
Valganciclovir therapy for immune recovery uveitis complicated by macular edema. Am J Ophthalmol (2004) 1.57
Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments. Am J Ophthalmol (2005) 1.56
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. Ophthalmology (2007) 1.51
Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology (2011) 1.49
Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis. Ophthalmology (2012) 1.46
Visual outcomes after wavefront-guided laser in situ keratomileusis with and without iris registration. J Cataract Refract Surg (2008) 1.42
Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina (2010) 1.39
HIV-associated retinopathy in the HAART era. Retina (2005) 1.27
Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina (2010) 1.26
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology (2006) 1.20
In vivo imaging of murine retinal ganglion cells. J Neurosci Methods (2007) 1.19
Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A (2012) 1.16
External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2012) 1.16
Avastin and new treatments for AMD: where are we? Retina (2006) 1.15
Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol (2009) 1.13
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest Ophthalmol Vis Sci (2004) 1.12
Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir. Invest Ophthalmol Vis Sci (2002) 1.10
Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.10
Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol (2011) 1.10
A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration. Hum Mol Genet (2011) 1.09
Multifocal electroretinography in HIV-positive patients without infectious retinitis. Am J Ophthalmol (2008) 1.08
Combined depth imaging technique on spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.07
Correspondence. Retina (2015) 1.06
Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials (2010) 1.05
Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.05
Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade. Invest Ophthalmol Vis Sci (2012) 1.04
The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm (2012) 1.03
Imaging of long-term retinal damage after resolved cotton wool spots. Ophthalmology (2009) 1.02
Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration. Retina (2011) 1.02
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol (2013) 1.02
Intravitreal crystalline drug delivery for intraocular proliferation diseases. Invest Ophthalmol Vis Sci (2009) 1.01
Lidocaine gel anesthesia for intravitreal drug administration. Retina (2005) 1.01
Spectral domain optical coherence tomography for imaging ERM, retinal edema, and vitreomacular interface. Retina (2010) 1.00
Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy. Retina (2002) 1.00
Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system. Invest Ophthalmol Vis Sci (2013) 0.99
Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities. Am J Ophthalmol (2010) 0.97
Machine learning classifiers detect subtle field defects in eyes of HIV individuals. Trans Am Ophthalmol Soc (2007) 0.97
Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina (2012) 0.96
Combined depth imaging using optical coherence tomography as a novel imaging technique to visualize vitreoretinal choroidal structures. Retina (2013) 0.94
Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol (2003) 0.94
Prophylactic intraoperative 360 degrees laser retinopexy for prevention of retinal detachment. Retina (2007) 0.94
Hyperreflective sign in resolved cotton wool spots using high-resolution optical coherence tomography and optical coherence tomography ophthalmoscopy. Ophthalmology (2007) 0.93
Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection. Br J Ophthalmol (2010) 0.93
A degenerative retinal process in HIV-associated non-infectious retinopathy. PLoS One (2013) 0.92
Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186. Curr Eye Res (2008) 0.92
Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Am J Ophthalmol (2013) 0.92
Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology (2007) 0.91
Observations by spectral-domain optical coherence tomography combined with simultaneous scanning laser ophthalmoscopy: imaging of the vitreous. Am J Ophthalmol (2010) 0.90
Characteristics and outcomes of choroidal neovascularization occurring after macular hole surgery. Retina (2004) 0.90